Sonic Healthcare (OTCMKTS:SKHHY) Sees Large Volume Increase - Should You Buy?

Key Points

• Sonic Healthcare experienced a significant increase in trading volume of 166%, with 204,952 shares traded compared to 77,068 shares previously.
• The stock's recent price was $14.69, reflecting a 0.6% decrease from its previous close of $14.81.
• A dividend of $0.3643 was announced, yielding 391.0%, with the payment scheduled for September 29th.

Sonic Healthcare Ltd. Sponsored ADR (OTCMKTS:SKHHY - ) saw an uptick in trading volume on Monday . 204,952 shares traded hands during mid-day trading, an increase of 166% from the previous session's volume of 77,068 shares.The stock last traded at $14.69 and had previously closed at $14.81.

Sonic Healthcare Stock Down 0.6%

The stock has a fifty day moving average of $16.92 and a 200 day moving average of $16.84.

Sonic Healthcare Dividend Announcement

The business also recently announced a dividend, which will be paid on Monday, September 29th. Investors of record on Friday, September 5th will be issued a $0.3643 dividend. This represents a yield of 391.0%. The ex-dividend date of this dividend is Thursday, September 4th.

About Sonic Healthcare

Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.